Tag: glycosylation in biosimilars
Manufacturing Challenges for Biosimilars: Complex Production and Why It’s Not Like Generic Drugs
- By : Tamsin Riverton
- Date : Dec 22 2025
Biosimilars aren't simple copies like generics-they're complex biologics made in living cells. This article breaks down the real manufacturing challenges: glycosylation, scale-up, cold chain risks, regulatory hurdles, and how new tech is helping manufacturers keep up.
